🇺🇸 FDA
Pipeline program

Mitoxantrone hydrochloride liposome injection30mg/m2

IIT2023004

Unknown small_molecule completed

Quick answer

Mitoxantrone hydrochloride liposome injection30mg/m2 for Acute Myeloid Leukemia is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Acute Myeloid Leukemia
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials